α-linolenic acid and docosahexaenoic acid, alone and combined with trastuzumab, reduce HER2-overexpressing breast cancer cell growth but differentially regulate HER2 signaling pathways

BACKGROUND: Diets rich in the n-3 fatty acid alpha-linolenic acid (ALA) have been shown to reduce breast tumor growth, enhance the effectiveness of the HER2-targeted drug trastuzumab (TRAS) and reduce HER2 signaling in mouse models. It is unclear whether this is due to direct effects of ALA or due t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mason, Julie K., Klaire, Sukhpreet, Kharotia, Shikhil, Wiggins, Ashleigh K A, Thompson, Lilian U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539855/
https://www.ncbi.nlm.nih.gov/pubmed/26282560
http://dx.doi.org/10.1186/s12944-015-0090-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539855/
https://www.ncbi.nlm.nih.gov/pubmed/26282560
http://dx.doi.org/10.1186/s12944-015-0090-6

Ejemplares similares